Mirabegron in Parkinson Disease and Impaired Cognition

NCT02536976 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

7

Enrollment

OTHER

Sponsor class

Conditions

Parkinson Disease
Overactive Bladder
Impaired Cognition

Interventions

DRUG: mirabegron
DRUG: Placebo

Sponsor

HealthPartners Institute